Welcome to our dedicated page for PROCORE TECHNOLOGIES SEC filings (Ticker: PCOR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Procore Technologies, Inc. filings document a public SaaS company whose common stock trades on the New York Stock Exchange under PCOR. Its reports and current filings cover operating and financial results for a subscription-based construction management platform, including revenue performance, customer metrics, guidance, and capital-structure disclosures.
Proxy statements and Form 8-K reports also record governance matters, director and executive officer appointments, committee assignments, compensation arrangements, stockholder voting items, risk factors, and material events tied to Procore's platform, business operations, and reporting obligations.
PROCORE TECHNOLOGIES, INC. Chairman of the Board Craig F. Courtemanche Jr. reported an exercise-and-sale transaction in the company’s common stock. On July 10, 2026, he exercised stock options for 56,122 shares at $2.42 per share and reported open‑market sales totaling 56,122 shares at weighted average prices of $43.63 and $44.76, with individual trades occurring between $43.31 and $45.26 per share. The sales were made pursuant to a Rule 10b5‑1 trading plan dated December 9, 2025. After these transactions, he holds 919,704 shares of Procore common stock directly, plus 168,366 stock options at $2.42 expiring on November 10, 2026, and additional indirect holdings through his spouse and several family trusts.
PCOR insider Craig F Courtemanche Jr filed a notice of intent to sell common stock. The filing lists a planned transaction involving 56,122 shares in connection with a stock option exercise through Morgan Stanley Smith Barney LLC Executive Financial Services, with trading on the NYSE dated 07/10/2026. Related figures of 2,463,301.21 and 150,890,216 are reported for this planned sale. The notice also reports prior common stock transactions over the past three months, including amounts tied to figures of 2,533,425.65 on 06/10/2026 and 2,865,392.89 on 05/11/2026.
Procore Technologies director Kevin J. O’Connor, through the Kevin J. O’Connor Revocable Trust, sold a total of 11,538 shares of Procore common stock in open‑market transactions on July 1–2, 2026 at weighted average prices around $42 per share. These sales were made pursuant to a pre‑arranged Rule 10b5‑1 trading plan dated March 13, 2026.
Following the most recent sale, the revocable trust held 962,132 shares indirectly, and O’Connor also held 21,344 shares directly. This filing shows a planned net‑sell transaction while he continues to retain a substantial equity stake in Procore Technologies.
Procore Technologies, Inc. disclosed that director Erin Chapple has decided to voluntarily resign from its Board of Directors, effective June 30, 2026. The company stated that her resignation is not due to any disagreement with Procore on its operations, policies, or practices.
Following her departure, the Board size will be reduced from 11 to 10 directors, effective immediately after her resignation becomes effective. This represents a board-size adjustment rather than a broader leadership overhaul.
Procore Technologies director Kevin J. O’Connor, through a revocable trust, reported open-market sales of a total of 11,544 shares of Common Stock. The sales occurred at weighted average prices ranging from $41.70 to $43.16 per share and were made pursuant to a Rule 10b5-1 trading plan dated March 13, 2026.
After these transactions, the trust associated with O’Connor still held 973,670 shares indirectly, while he also reported 21,344 shares held directly. The filing indicates continued substantial ownership despite these pre-planned, net-selling transactions.
PCOR affiliate submitted a Form 144 notice proposing sale of Common Stock. The filing lists securities to be sold and records two recent dispositions by the Kevin J O'Connor Revocable Trust dtd 06/13/19: 5,769 shares on 04/15/2026 for $294,606.68 and 5,769 shares on 04/16/2026 for $307,879.42. The filing also notes the shares were originally acquired from the issuer on 12/20/2006.
Procore Technologies chairman Craig F. Courtemanche Jr. reported a mix of stock option exercises, share sales, and structured financing tied to his holdings. He exercised stock options for 56,122 shares of Common Stock at $2.42 per share, increasing his direct stake, and then sold 42,421 shares at $45.29 and 13,701 shares at $44.69 in open-market transactions. The sales were made under a pre-arranged Rule 10b5-1 trading plan dated December 9, 2025, and left him with 975,826 directly held shares. Separately, the Craig F. Courtemanche and Hillary Courtemanche Family Trust and the Courtemanche 2021 Irrevocable Trust entered into revolving loan and collar transactions with a bank covering 1,700,000 pledged shares, using European call and put options with strike prices of $60.9986 and $37.5716 and expirations in June 2029 for general liquidity purposes, while generally retaining voting and dividend rights on the pledged stock.
Morgan Stanley Smith Barney LLC submitted a Form 144 disclosing an intended sale of 56,122 shares of Common Stock on 06/10/2026 related to a stock option exercise. The filing lists prior dispositions of 56,122 shares on 05/11/2026 and 04/10/2026 with dollar amounts shown alongside each transaction.
Griffith William J.G. reported acquisition or exercise transactions in this Form 4 filing.
PROCORE TECHNOLOGIES, INC. director William J.G. Griffith reported an award of 4,712 restricted stock units (RSUs) of common stock at a price of $0.00 per share. These RSUs vest in full at the company’s 2027 annual meeting of stockholders, subject to his continued board service.
Settlement of the RSUs into common stock has been deferred until the earlier of 90 days after his service ends or a change in control. According to the footnotes, any proceeds from sales of shares issued upon RSU settlement will be transferred to ICONIQ Capital, LLC, and Griffith disclaims beneficial ownership except to the extent of any pecuniary interest.
The Form 4 also lists sizeable indirect holdings of Procore common stock through multiple ICONIQ Strategic Partners funds and estate-planning trusts, with a post-transaction direct and RSU-related position of 3,249,258 shares reported, reflecting his broad economic exposure rather than a new open‑market trade.
SMITH GRAHAM reported acquisition or exercise transactions in this Form 4 filing.
PROCORE TECHNOLOGIES, INC. director Graham Smith received an equity award of 4,712 restricted stock units (RSUs), each representing one share of common stock upon settlement. After this grant, he holds 54,381 shares (including the RSUs reported in the filing).
All 4,712 RSUs are scheduled to vest on the date of Procore’s 2027 annual meeting of stockholders, or immediately before that date if his board service ends at that meeting due to not being re-elected or not standing for re-election. Smith has elected to defer settlement of the vested RSUs into common stock until the earlier of 90 days after his service terminates or a change in control of the company.